Orum Therapeutics Corrects Stock Option Exercise Deadline to October 2031 From October 2036

Bitget2026/10/22 05:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Orum Therapeutics corrected its shareholder meeting notice on Oct. 22, 2026, shortening Geoffrey Harris Meyerson’s stock option exercise period.
The corrected period runs from Oct. 24, 2028, through Oct. 23, 2031, rather than Oct. 23, 2036.
The U.S. subsidiary’s proposed 85,663-share option grant comprises 73,741 shares for CSO Chad May and 11,922 shares for three employees.
A previously omitted March 27, 2026, grant of 102,223 shares raises total options granted across the reported periods to 799,964 shares.
Remaining options across those periods were corrected to 729,780 shares from 627,557 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orum Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261022000137), on October 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Orum Therapeutics Corrects Stock Option Exercise Deadline to October 2031 From October 2036

You may also like

Crypto prices